NorthStar marks milestone in non-uranium production of Mo-99

January 12, 2023, 12:02PMNuclear News

IBA Rhodotron TT300-HE (high energy) electron accelerator. (Photo: Business Wire)

Nuclear medicine company NorthStar Medical Radioisotopes announced that it has successfully produced molybdenum-99 at its recently completed accelerator production facility at its Beloit, Wis., campus. According to NorthStar, the event marks a major milestone in advancing the company’s proprietary electron accelerator technology for the non-uranium–based production of the critical medical radioisotope.

To continue reading, log in or create a free account!

Orano completes transport & disposal of Crystal River-3 RPV

October 9, 2024, 9:29AMRadwaste Solutions

Orano USA announced that it has recently completed the transportation and disposal of the dismantled Crystal River Unit 3 reactor using only four large packages, which were shipped more than...

Missouri radioisotope producer MURR joins European nuclear medicine group

July 22, 2024, 9:30AMNuclear News

The University of Missouri Research Reactor (MURR) is the latest member of Nuclear Medicine Europe, an industry association for the radiopharmaceutical and molecular imaging industry in...

NRC approves transfer of Vallecitos to North Star for D&D

May 2, 2024, 7:01AMRadwaste Solutions

By an order dated April 25, the Nuclear Regulatory Commission has approved the transfer of ownership of Vallecitos Nuclear Center from GE Hitachi Nuclear Energy to NorthStar Group Services for...

Orano completes removal of Crystal River-3 RPV

December 11, 2023, 6:58AMRadwaste Solutions

The cutting and conditioning of the reactor pressure vessel (RPV) and internals belonging to the pressurized water reactor at the Crystal River-3 nuclear power plant in Florida has been...

Westinghouse, TerraPower join the Ac-225 supply chain

June 29, 2023, 9:30AMNuclear News

Westinghouse and TerraPower, in conjunction with Belgium’s Pan Tera, have announced plans to produce large quantities of actinium-225, a radioisotope used for targeted alpha radiation...

Serva Energy teams with research reactor to produce cancer-fighting Ac-225

June 27, 2023, 7:00AMNuclear News

Serva Energy has developed a research reactor–based method of actinium-225 production, the company announced on June 22, saying it “marks the first time a commercial entity has employed a...

World Astatine Community expands access to cancer-fighting At-211

June 20, 2023, 12:00PMNuclear News

The World Astatine Community (WAC) was formed earlier this year during the 12th International Symposium for Targeted Alpha Therapy by representatives from the United States, Japan, and the...

NorthStar to take ownership of Vallecitos for D&D

May 11, 2023, 3:00PMRadwaste Solutions

GE Hitachi Nuclear Energy announced May 9 that it intends to transfer ownership of the 1,600-acre GEH Vallecitos Nuclear Center to NorthStar Group Services for nuclear decontamination,...

Shipping Vermont Yankee’s LLW: Lessons for transporting used fuel

March 23, 2023, 9:30AMRadwaste SolutionsJay Thomas, Mike Valenzano, and Nicolas Guibert

The rapid changes in the nuclear energy industry over the last decade, driven in part by fluctuating energy market prices and an aging fleet of reactors, have led to the closure of multiple...

SHINE receives final EIS to operate its Mo-99 production facility

February 8, 2023, 9:30AMNuclear News

The Nuclear Regulatory Commission has issued the final supplemental environmental impact statement (EIS) for SHINE Technology’s application for a license to operate a medical isotope...

NorthStar marks milestone in non-uranium production of Mo-99

Related Articles